This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. AIKI, LUNA, DKDCA, IGMS, UNCY, INCR, ASRT, PMVP, OSTX, and APLTShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include AIkido Pharma (AIKI), Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), IGM Biosciences (IGMS), Unicycive Therapeutics (UNCY), InterCure (INCR), Assertio (ASRT), PMV Pharmaceuticals (PMVP), OS Therapies (OSTX), and Applied Therapeutics (APLT). Bioanalytical Systems vs. Its Competitors AIkido Pharma Luna Innovations Data Knights Acquisition IGM Biosciences Unicycive Therapeutics InterCure Assertio PMV Pharmaceuticals OS Therapies Applied Therapeutics AIkido Pharma (NASDAQ:AIKI) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation. Which has more volatility & risk, AIKI or BASI? AIkido Pharma has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Do insiders and institutionals believe in AIKI or BASI? 10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by insiders. Comparatively, 11.5% of Bioanalytical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor AIKI or BASI? In the previous week, AIkido Pharma's average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score. Company Overall Sentiment AIkido Pharma Neutral Bioanalytical Systems Neutral Is AIKI or BASI more profitable? AIkido Pharma has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. AIkido Pharma's return on equity of -18.21% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Bioanalytical Systems -7.75%-42.74%-6.38% Which has stronger earnings & valuation, AIKI or BASI? Bioanalytical Systems has higher revenue and earnings than AIkido Pharma. Bioanalytical Systems is trading at a lower price-to-earnings ratio than AIkido Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido PharmaN/AN/A-$7.17M-$3.88-1.55Bioanalytical Systems$60.47M0.29-$4.68M-$0.35-4.57 SummaryBioanalytical Systems beats AIkido Pharma on 6 of the 10 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.81M$21.59M$5.77B$9.77BDividend YieldN/AN/A6.66%4.49%P/E Ratio-3.81N/A82.3726.60Price / Sales0.290.28536.82175.38Price / Cash558.4057.2325.7028.92Price / Book2.320.3110.646.56Net Income-$4.68M-$525K$3.28B$266.04M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$1.60-5.3%N/A+12.7%$17.81M$60.47M-3.81397High Trading VolumeAIKIAIkido PharmaN/A$6.22-4.0%N/A+306.3%$34.12MN/A-1.604High Trading VolumeLUNALuna Innovations0.0635 of 5 stars$0.85+6.3%N/A-62.2%$28.87M$116.61M0.00390Gap DownDKDCAData Knights AcquisitionN/A$0.76-2.1%N/A-16.5%$3.95MN/A-4.022Gap UpHigh Trading VolumeIGMSIGM Biosciences4.5779 of 5 stars$1.27flat$5.50+333.1%N/A$76.57M$145.05M-1.41190Positive NewsUNCYUnicycive Therapeutics3.2799 of 5 stars$4.25-0.9%$60.00+1,311.8%+27.9%$75.77MN/A-1.039INCRInterCure0.7041 of 5 stars$1.64-1.5%N/A-28.9%$75.65M$238.85M0.00350Positive NewsASRTAssertio2.2572 of 5 stars$0.78-0.6%$2.38+204.2%-32.7%$75.61M$124.96M-1.7420PMVPPMV Pharmaceuticals3.4509 of 5 stars$1.44+1.4%$5.50+281.9%-5.1%$75.25MN/A-0.9250Positive NewsHigh Trading VolumeOSTXOS Therapies2.0941 of 5 stars$2.33+6.4%$18.00+672.5%-46.1%$74.31MN/A-2.95N/ANews CoverageAnalyst ForecastAPLTApplied Therapeutics4.1419 of 5 stars$0.53+3.7%$6.10+1,043.4%-91.8%$74.09M$460K-1.1930Positive News Related Companies and Tools Related Companies AIkido Pharma Competitors Luna Innovations Competitors Data Knights Acquisition Competitors IGM Biosciences Competitors Unicycive Therapeutics Competitors InterCure Competitors Assertio Competitors PMV Pharmaceuticals Competitors OS Therapies Competitors Applied Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BASI Stock Alerts